28233467|t|Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease
28233467|a|Mitochondrial disease (MD) is a genetic disorder affecting skeletal muscles, with possible myocardial disease. The ergoreflex, sensitive to skeletal muscle work, regulates ventilatory and autonomic responses to exercise. We hypothesized the presence of an increased ergoreflex sensitivity in MD patients, its association with abnormal ventilatory and autonomic responses, and possibly with subclinical cardiac involvement. Twenty-five MD patients (aged 46 Â± 3 years, 32% male) with skeletal myopathy but without known cardiac disease, underwent a thorough evaluation including BNPs, galectin-3, soluble suppression of tumorigenesis 2 (sST2), high sensitivity troponin T/I, catecholamines, ECG, 24-h ECG recording, cardiopulmonary exercise testing, echocardiography, cardiac/muscle magnetic resonance (C/MMR), and ergoreflex assessment. Thirteen age- and sex-matched healthy controls were chosen. Among these myopathic patients, subclinical cardiac damage was detected in up to 80%, with 44% showing fibrosis at CMR. Ergoreflex sensitivity was markedly higher in patients than in controls (64% vs. 37%, P < 0.001), and correlated with muscle fat to water ratio and extracellular volume at MMR (both P < 0.05). Among patients, ergoreflex sensitivity was higher in those with cardiac involvement (P = 0.034). Patients showed a lower peak oxygen consumption (VO2 /kg) than controls (P < 0.001), as well as ventilatory inefficiency (P = 0.024). Ergoreflex sensitivity correlated with reduced workload and peak VO2 /kg (both P < 0.001), and several indicators of autonomic imbalance (P < 0.05). Plasma norepinephrine was the unique predictor of myocardial fibrosis at univariate analysis (P < 0.05). Skeletal myopathy in MD is characterized by enhanced ergoreflex sensitivity, which is associated with a higher incidence of cardiac involvement, exercise intolerance, and sympathetic activation.
28233467	0	9	Autonomic	T033	UMLS:C1837624
28233467	11	21	functional	T017	UMLS:C0302142
28233467	23	38	skeletal muscle	T017	UMLS:C0302142
28233467	44	65	cardiac abnormalities	T017	UMLS:C0018798
28233467	96	118	ergoreflex sensitivity	T033	UMLS:C0243095
28233467	122	143	mitochondrial disease	T038	UMLS:C0751651
28233467	144	165	Mitochondrial disease	T038	UMLS:C0751651
28233467	167	169	MD	T038	UMLS:C0751651
28233467	176	192	genetic disorder	T038	UMLS:C0019247
28233467	203	219	skeletal muscles	T017	UMLS:C0242692
28233467	235	253	myocardial disease	T038	UMLS:C0878544
28233467	259	269	ergoreflex	T038	UMLS:C0034929
28233467	284	299	skeletal muscle	T017	UMLS:C0242692
28233467	306	315	regulates	T038	UMLS:C1327622
28233467	316	327	ventilatory	T201	UMLS:C1321070
28233467	410	432	ergoreflex sensitivity	T033	UMLS:C0243095
28233467	436	438	MD	T038	UMLS:C0751651
28233467	470	478	abnormal	T033	UMLS:C0205161
28233467	479	490	ventilatory	T201	UMLS:C1321070
28233467	534	565	subclinical cardiac involvement	T033	UMLS:C0243095
28233467	579	581	MD	T038	UMLS:C0751651
28233467	615	619	male	T098	UMLS:C0025266
28233467	626	643	skeletal myopathy	T038	UMLS:C1533847
28233467	662	677	cardiac disease	T038	UMLS:C0018799
28233467	700	710	evaluation	T058	UMLS:C0220825
28233467	721	725	BNPs	T058	UMLS:C1095989
28233467	727	737	galectin-3	T058	UMLS:C3496493
28233467	739	758	soluble suppression	T058	UMLS:C0201782
28233467	762	777	tumorigenesis 2	T038	UMLS:C0007621
28233467	779	783	sST2	T058	UMLS:C0201782
28233467	803	815	troponin T/I	T058	UMLS:C0523952
28233467	817	831	catecholamines	T058	UMLS:C0546632
28233467	833	836	ECG	T033	UMLS:C0013798
28233467	838	856	24-h ECG recording	T033	UMLS:C0013798
28233467	858	890	cardiopulmonary exercise testing	T058	UMLS:C2959886
28233467	892	908	echocardiography	T058	UMLS:C0013516
28233467	910	943	cardiac/muscle magnetic resonance	T058	UMLS:C0024485
28233467	945	950	C/MMR	T058	UMLS:C0024485
28233467	957	978	ergoreflex assessment	T058	UMLS:C0220825
28233467	1052	1061	myopathic	T038	UMLS:C0026848
28233467	1072	1098	subclinical cardiac damage	T033	UMLS:C0243095
28233467	1103	1111	detected	T033	UMLS:C0442726
28233467	1143	1151	fibrosis	T038	UMLS:C0016059
28233467	1155	1158	CMR	T058	UMLS:C0024485
28233467	1160	1182	Ergoreflex sensitivity	T033	UMLS:C0243095
28233467	1308	1321	extracellular	T017	UMLS:C0521119
28233467	1332	1335	MMR	T058	UMLS:C0024485
28233467	1369	1391	ergoreflex sensitivity	T033	UMLS:C0243095
28233467	1417	1436	cardiac involvement	T033	UMLS:C0243095
28233467	1479	1497	oxygen consumption	T201	UMLS:C0030055
28233467	1499	1502	VO2	T201	UMLS:C0030055
28233467	1546	1570	ventilatory inefficiency	T033	UMLS:C3540840
28233467	1584	1606	Ergoreflex sensitivity	T033	UMLS:C0243095
28233467	1649	1652	VO2	T201	UMLS:C0030055
28233467	1701	1720	autonomic imbalance	T038	UMLS:C0262385
28233467	1733	1739	Plasma	T031	UMLS:C0032105
28233467	1740	1754	norepinephrine	T103	UMLS:C0028351
28233467	1783	1802	myocardial fibrosis	T038	UMLS:C0151654
28233467	1838	1855	Skeletal myopathy	T038	UMLS:C1533847
28233467	1859	1861	MD	T038	UMLS:C0751651
28233467	1891	1913	ergoreflex sensitivity	T033	UMLS:C0243095
28233467	1962	1981	cardiac involvement	T033	UMLS:C0243095
28233467	1983	2003	exercise intolerance	T033	UMLS:C0424551